| 155.71 Delayed Data As of Nov 16 |  +2.59 / +1.69%Today’s Change | 106.07 Today|||52-Week Range 175.00 | +38.15% Year-to-Date |
| Sands Capital Management Buys Sarepta Therapeutics Inc, Edwards Lifesciences Corp, Ab... Nov 14 / GuruFocus News - Paid Partner Content | Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should Know Nov 05 / Zacks.com - Paid Partner Content |
| Previous close | 153.12 |
| Today’s open | 151.93 |
| Day’s range | 150.83 - 157.32 |
| Volume | 1,411,361 |
| Average volume (3 months) | 1,576,844 |
| Market cap | $32.0B |
| Earnings growth (last year) | +3.75% |
| Earnings growth (this year) | +23.67% |
| Earnings growth (next 5 years) | +17.80% |
| Revenue growth (last year) | +15.91% |
| P/E ratio | 46.8 |
| Price/Sales | 7.08 |
| Price/Book | 10.86 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNNSmith & Nephew PLC | +0.12 | +0.33% |
| STESTERIS plc | +0.22 | +0.19% |
| HRCHill-Rom Holdings In... | +1.67 | +1.80% |
| ISRGIntuitive Surgical | +4.90 | +0.95% |
| Next reporting date | February 11, 2019 |
| EPS forecast (this quarter) | $1.17 |
| Annual revenue (last year) | $3.4B |
| Annual profit (last year) | $583.6M |
| Net profit margin | 16.99% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Michael A. Mussallem |
Chief Financial Officer & Vice President Scott B. Ullem |
Corporate headquarters Irvine, California |
